MedPath

A prospective randomized study for the effect of lanthanum carbonate on FGF23 in patients with chronic kidney disease at predialysis stage.

Not Applicable
Conditions
chronic kidney disease
Registration Number
JPRN-UMIN000016709
Lead Sponsor
Kitasato University Department of Nephrology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1) Exclusion criteria were known hypersensitivity to lanthanum carbonate and calcium carbonate, and pregnancy or lactation. 2) Any reason for ineligibility suggested by the attending doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
FGF23 at month 1, 2, 3, 4
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath